Frank David

Frank David is a physician scientist and expert in the intersection of corporate strategy, clinical medicine, and biotech research. He has extensive experience advising clients on biotech financial modeling and valuation. Frank has a strong background in medicine and has worked in various roles, including as a researcher and a clinician. He has a deep understanding of the biotech industry and has developed expertise in financial modeling and valuation. Frank is the founder and managing director of Pharmagellan, a consulting firm that specializes in biotech financial modeling and valuation. He is known for his expertise in the field and his ability to provide insightful advice to clients.